Feasibility of Web-based Therapy Sessions

NCT07560696 | Recruiting

• 1 other identifier: LHS0204
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders. The main question it aims to answer is: " Is it feasible to use a web-based platform for delivering rehabilitation treatment in a large acute National Health Care Organisation" Participants will undergo therapy sessions prescribed by therapists on a web-based platform instead of the conventional paper-based therapy sessions for their cognitive and speech rehabilitation needs.

Conditions

Cognitive Impairment; Acquired Brain Injury; Speech Dysfunction

Outcome Measures

Primary Outcomes (1)

• To assess the feasibility of using the Cognishine web-based platform in a large NHS Trust in acute care setting.

  Total number of completed sessions per patient on the cognishine platform

  From recruitment until discharge from rehabilitation therapy or discharge from hospital, which ever comes first. Time frames will vary dependent on patient recovery .The anticipated time frame is 1 to 6 months. Maximum follow up is 12 months.

Secondary Outcomes (5)

• To assess staff and patient experience of using the Cognishine platform during therapy sessions.

  Patients will be asked to complete this on discharge from hospital. Therapists will be asked to complete the questionnaire one month after starting the study (in the middle of recruitment)

• To generate qualitative data about how to improve the end user experience for therapist to target barriers to implementation

  12 month into the study.

• To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform.

  As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 months.

• To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform.

  As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 months

• To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform.

  As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 months.

Study Arms (1)

Web-based patient-led therapy sessions

EXPERIMENTAL

All patients will receive standard of care rehabilitation. In addition, patients recruited into the study will use the Cognishine platform for cognitive and/or language rehabilitation

Behavioral: a Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders

Interventions

a Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders BEHAVIORAL

The Cognishine platform is a digital (web-based) general health and wellness monitoring platform. It is designed to support health care professionals specialised in rehabilitation of patients with neurological disorders, through a wide range of multi-media based generalised activities across speech, language, social-emotional, and cognition.

Web-based patient-led therapy sessions

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with cognitive impairment and/or speech impairment being treated at the LUHFT Intensive Care Units and the Stroke wards
• Need for Cognitive and/or speech and Language rehabilitation

You may not qualify if:

• Inability to obtain consent
• Refusal to take part in the study
• Failure to engage with the Cognishine platform
• Inability to operate a mobile device/ tablet with support
• Unavailability of study therapist to provide training of patients
• Unstable medical condition

Sponsors & Collaborators

• Liverpool University Hospitals NHS Foundation Trust: lead
• Israel Innovation Authority: collaborator

Study Sites (1)

Liverpool University Hospitals NHS Foundation Trust

Liverpool, l7 8xp, United Kingdom

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction; Brain Injuries

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Craniocerebral Trauma; Trauma, Nervous System; Wounds and Injuries

Study Officials

• Matthew Noonan

  Liverpool University Hospitals NHS Foundation Trust

  STUDY CHAIR

Central Study Contacts

Vinoth Sankar

CONTACT

+044 0151 706 2000; Vinoth.Sankar@liverpoolft.nhs.uk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 7, 2026
• First Posted: May 1, 2026
• Study Start: July 3, 2024
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: May 1, 2026

Record last verified: 2026-02

Locations

GB (1)